{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:54:30Z","timestamp":1787799270863,"version":"build-2784847793"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.rpth.2023.100161","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T12:02:45Z","timestamp":1682337765000},"page":"100161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias"],"prefix":"10.1016","volume":"7","author":[{"given":"Maureen K.","family":"Baldwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Samuelson Bannow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Rosovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Sokkary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi V.","family":"Srivaths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.100161_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: considerations for prevention and management","volume":"6","author":"LaVasseur","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100161_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1182\/hematology.2020000140","article-title":"Women and bleeding disorders: diagnostic challenges","volume":"2020","author":"James","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2023.100161_bib3","doi-asserted-by":"crossref","first-page":"202.e1","DOI":"10.1016\/j.ajog.2013.05.059","article-title":"The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynecologic abnormalities","volume":"209","author":"Knol","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rpth.2023.100161_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2516.2000.00447.x","article-title":"Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey","volume":"6","author":"Kouides","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.100161_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/hae.12014","article-title":"Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life","volume":"19","author":"Rae","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.100161_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"Samuelson Bannow","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100161_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106714","article-title":"Women\u2019s representation in venous thromboembolism randomized trials and registries: the illustrative example of direct oral anticoagulants for acute treatment","volume":"115","author":"Bikdeli","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.rpth.2023.100161_bib8","first-page":"1","article-title":"U.S. Medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.rpth.2023.100161_bib9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/GME.0000000000001241","article-title":"The 2017 hormone therapy position statement of the North American Menopause Society","volume":"25","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.rpth.2023.100161_bib10","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.rpth.2023.100161_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/cmt.4.4.267.272","article-title":"Executive summary: Stages of Reproductive Aging Workshop (STRAW)","volume":"4","author":"Soules","year":"2001","journal-title":"Climacteric"},{"key":"10.1016\/j.rpth.2023.100161_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.maturitas.2013.07.009","article-title":"Contraception during the perimenopause","volume":"76","author":"Baldwin","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.rpth.2023.100161_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.rpth.2023.100161_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13625180600772741","article-title":"Metabolic and clinical effects of progestogens","volume":"11","author":"Wiegratz","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.rpth.2023.100161_bib15","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2023.100161_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rpth.2023.100161_bib18","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2023.100161_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/09513590.2016.1161743","article-title":"Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4 mg formulation in a 24\u00a0+ 4 cycle with desogestrel 75 \u03bcg per day","volume":"32","author":"Regidor","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.rpth.2023.100161_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(98)00045-6","article-title":"A\u00a0randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75 microgram desogestrel or 30 microgram levonorgestrel","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0024363918816683","article-title":"Systematic review of hormonal contraception and risk of venous thrombosis","volume":"85","author":"Keenan","year":"2018","journal-title":"Linacre Q"},{"key":"10.1016\/j.rpth.2023.100161_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.thromres.2012.03.029","article-title":"Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial","volume":"130","author":"Brito","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100161_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rpth.2023.100161_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ogc.2015.07.007","article-title":"Does the progestogen used in combined hormonal contraception affect venous thrombosis risk?","volume":"42","author":"Han","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.rpth.2023.100161_bib25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100161_bib26","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/jc.2007-0044","article-title":"Formation of ethinyl estradiol in women during treatment with norethindrone acetate","volume":"92","author":"Chu","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2023.100161_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.thromres.2018.06.014","article-title":"Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis","volume":"168","author":"Rovinski","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100161_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/GME.0000000000000611","article-title":"Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration","volume":"23","author":"Bergendal","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.rpth.2023.100161_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/bcpt.13644","article-title":"Does administration of vaginal estrogens increase the risk of venous thromboembolism: a case-control study","volume":"129","author":"Svendsen","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.rpth.2023.100161_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/GME.0000000000000373","article-title":"Algorithm and mobile app for menopausal symptom management and hormonal\/non-hormonal therapy decision making: a clinical decision-support tool from the North American Menopause Society","volume":"22","author":"Manson","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.rpth.2023.100161_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-022-06647-5","article-title":"Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review","author":"Gold\u0161tajn","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.rpth.2023.100161_bib33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinte.166.7.772","article-title":"Venous thrombosis and conjugated equine estrogen in women without a uterus","volume":"166","author":"Curb","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2023.100161_bib34","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/jc.2015-2237","article-title":"Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis","volume":"100","author":"Mohammed","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.rpth.2023.100161_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2023.100161_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1373\/clinchem.2018.288316","article-title":"Venous thrombotic risk in transgender women undergoing estrogen therapy: a systematic review and metaanalysis","volume":"65","author":"Khan","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.rpth.2023.100161_bib37","first-page":"209","article-title":"Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy","volume":"10","author":"Goldstein","year":"2019","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.rpth.2023.100161_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ajh.24593","article-title":"Thrombotic issues in transgender medicine: a review","volume":"92","author":"Shatzel","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2023.100161_bib39","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"key":"10.1016\/j.rpth.2023.100161_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2018.03.005","article-title":"Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose","volume":"165","author":"Oedingen","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100161_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: a bench to bedside review","volume":"192","author":"Abou-Ismail","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100161_bib42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.rpth.2023.100161_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(01)00234-7","article-title":"Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis","volume":"64","author":"Hennessy","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib44","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2023.100161_bib45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100161_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/rth2.12290","article-title":"VTE risk assessment in pregnancy","volume":"4","author":"Ewins","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100161_bib47","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100161_bib48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous\u00a0thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100161_bib49","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1055\/s-0040-1722611","article-title":"Pregnancy-associated venous thromboembolism: insights from Garfield-VTE","volume":"5","author":"Jerjes-S\u00e1nchez","year":"2021","journal-title":"TH Open"},{"key":"10.1016\/j.rpth.2023.100161_bib50","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/j.amjmed.2019.03.039","article-title":"Inappropriate testing and treatment of factor V Leiden and other heritable thrombophilias","volume":"132","author":"Parsons","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2023.100161_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620939181","article-title":"Position paper on the management of pregnancy-associated superficial venous thrombosis. Balkan working group for prevention and treatment of venous thromboembolism","volume":"28","author":"Antic","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.100161_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.amjms.2016.08.007","article-title":"Cardiovascular disease risk associated with the long-term use of depot medroxyprogesterone acetate","volume":"352","author":"Dilshad","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rpth.2023.100161_bib53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00198-016-3714-4","article-title":"The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK","volume":"28","author":"Kyvernitakis","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.rpth.2023.100161_bib54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.contraception.2006.03.010","article-title":"Bone mineral density in women aged 25\u201335 years receiving depot medroxyprogesterone acetate: recovery following discontinuation","volume":"74","author":"Kaunitz","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib55","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00198-020-05437-6","article-title":"Effect of progestogen-only contraception on premenopausal fracture risk: a case-control study","volume":"31","author":"Kyvernitakis","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.rpth.2023.100161_bib56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.contraception.2016.04.016","article-title":"Safety of hormonal contraceptives among women with migraine: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rpth.2023.100161_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bpobgyn.2019.09.003","article-title":"Contraception and preconception counseling in women with autoimmune disease","volume":"64","author":"Sammaritano","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.rpth.2023.100161_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2023.100161_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.thromres.2016.06.012","article-title":"Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: the longitudinal investigation of thromboembolism etiology","volume":"144","author":"Cushman","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100161_bib61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2016.10.010","article-title":"Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review","volume":"95","author":"Dragoman","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2217\/WHE.13.41","article-title":"Obesity and hormonal contraceptive efficacy","volume":"9","author":"Robinson","year":"2013","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.rpth.2023.100161_bib63","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100161_bib64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.contraception.2011.10.008","article-title":"Contraception for individuals with sickle cell disease: a systematic review of the literature","volume":"85","author":"Haddad","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(82)90320-8","article-title":"Medroxyprogesterone acetate and homozygous sickle-cell disease","volume":"2","author":"De Ceulaer","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100161_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(97)00156-X","article-title":"Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients","volume":"56","author":"de Abood","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2023.100161_bib67","first-page":"CD000249","article-title":"Antifibrinolytics for heavy menstrual bleeding","volume":"4","author":"Bryant-Smith","year":"2018","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:26:07Z","timestamp":1762863967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2475037923001346"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100161","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"100161"}}